MXCT insider buying
Every open-market purchase of Maxcyte, Inc. (MXCT) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
In the last 12 months, 1 insider of Maxcyte, Inc. bought $120.78K of MXCT stock on the open market in 1 reported purchase. The most recent was filed on Nov 18, 2026: Masoud Maher (President and CEO, Director) bought 100,000 shares at $1.21, worth $120.78K. MXCT last closed at $1.25 on Nov 18, 2026: taken together, the insider purchases listed here are up 3% since they were made (split-adjusted, weighted by amount).
New to insider data? Read how to read a Form 4 and which insider buys matter.
Get the next MXCT insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll MXCT insider purchases
| Filed | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|
| Nov 18 | Masoud MaherPresident and CEO, Director | $120.78K | 100,000 | $1.21 | +3.5% | +21% | Nov 17 | SEC |